CERT Stock Analysis Today
Updated Nov 6, 2026 · trends, key levels, insider activity and news
Is CERT bullish or bearish today?
Daily trend: Uptrend (confirmed) — turns down below $8.58
SEPT signal: Institutional Drive · Strong Bullish
Research grade: B · fair value $12.49 (-21.7%)
CERT trend by timeframe
| Daily | Uptrend (confirmed) |
|---|---|
| 4 hour | Strong Bullish |
| 1 hour | Expanding |
| 15 min | Strong Bullish |
| 5 min | Strong Bullish |
Trends are calculated from price structure and update during market hours.
CERT support and resistance levels
Resistance (above)
$12.411 touches
$12.943 touches
$13.882 touches
Support (below)
$11.7315 touches
$11.002 touches
$10.4615 touches
Upside zones: $8.60 / $8.99 / $9.37
See all levels on the live chart →Insider and institutional activity
Insiders
Neutral30-day buys / sells
0 / 030-day net
—Hedge fund holders
197Latest CERT news and filings
- NewsFiscal.ai
Certara named a leader in AI predictive toxicology market
Certara has been identified as a leader in the market for AI-powered predictive toxicology. The recognition highlights its position in this area of drug safety testing.
- AnalystBenzinga
KeyBanc Keeps Overweight Rating on Certara, Lifts Price Target to $12
KeyBanc reiterated its Overweight rating on Certara and raised its price target to $12. The move reflects the analyst's updated view on the stock.
- AnalystBenzinga
TD Cowen Keeps Buy Rating on Certara, Lifts Price Target to $11
TD Cowen reiterated its Buy rating on Certara and raised its price target to $11. The analyst update reflects a higher expected value for the shares.
- AnalystBenzinga
Barclays keeps Equal-Weight on Certara, lifts target to $9
Barclays reiterated an Equal-Weight rating on Certara and raised its price target to $9. The update reflects the firm's latest view on the stock.
- LegalBenzinga
HHS starts project to accelerate clinical trials
The Department of Health and Human Services is launching a project aimed at making clinical trials faster. The effort focuses on speeding up how trials are run.
- AnalystBenzinga
UBS Downgrades Certara to Neutral, Keeps $10 Price Target
UBS lowered its rating on Certara to Neutral from its prior rating while keeping a $10 price target on the shares.
Live CERT chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Why is CERT stock moving today?
Nov 5, 2026: Certara shares closed at $12.18, up 8.65% on volume of 3.67 million, after the company reported third-quarter results and held its earnings call. Adjusted EPS of $0.09 met expectations, while revenue of $94.901 million topped the $92.867 million consensus, a bullish signal that likely drove the gain.
Is CERT bullish or bearish today?
CERT daily trend: Uptrend (confirmed) — turns down below $8.58. SEPT signal: Institutional Drive (Strong Bullish). Updated Nov 6, 2026.
What is CERT's trend on each timeframe?
Daily: Uptrend (confirmed); 4 hour: Strong Bullish; 1 hour: Expanding; 15 min: Strong Bullish; 5 min: Strong Bullish.
What are CERT support and resistance levels?
Support: $11.73, $11.00, $10.46. Resistance: $12.41, $12.94, $13.88. Last price $12.18.
Are insiders buying or selling CERT?
Insider signal: Neutral. Last 30 days: 0 buys, 0 sells. 197 hedge funds hold CERT.
What is the latest news on CERT?
Oct 27, 2026: Certara named a leader in AI predictive toxicology market · Oct 16, 2026: KeyBanc Keeps Overweight Rating on Certara, Lifts Price Target to $12 · Oct 13, 2026: TD Cowen Keeps Buy Rating on Certara, Lifts Price Target to $11